|
RFK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.358700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.997900E-02 |
| Normal-vs-Stage2 |
7.799600E-02 |
| Normal-vs-Stage3 |
5.160800E-04 |
| Normal-vs-Stage4 |
3.305200E-01 |
| Stage1-vs-Stage2 |
9.408000E-01 |
| Stage1-vs-Stage3 |
9.894600E-01 |
| Stage1-vs-Stage4 |
5.106800E-01 |
| Stage2-vs-Stage3 |
9.371200E-01 |
| Stage2-vs-Stage4 |
6.108600E-01 |
| Stage3-vs-Stage4 |
4.445000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.536900E-03 |
| Normal-vs-AfricanAmerican |
4.0601000000029E-05 |
| Normal-vs-Asian |
1.605690E-02 |
| Caucasian-vs-AfricanAmerican |
5.286800E-01 |
| Caucasian-vs-Asian |
6.797000E-01 |
| AfricanAmerican-vs-Asian |
9.208800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.563000E-04 |
| Normal-vs-Female |
2.930000E-02 |
| Male-vs-Female |
3.542400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.793500E-02 |
| Normal-vs-Extreme_Weight |
1.09729999975272E-07 |
| Normal-vs-Obese |
8.094800E-01 |
| Normal-vs-Extreme_Obese |
3.29249999997394E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.336800E-01 |
| Normal_Weight-vs-Obese |
4.918800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.318200E-02 |
| Extreme_Weight-vs-Obese |
1.919180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.472600E-01 |
| Obese-vs-Extreme_Obese |
8.508100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.688800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.954500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.909610E-02 |
| Normal-vs-Age(81-100Yrs) |
1.79058999999482E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.449600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.508000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.135420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.947600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.057700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.227400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.83339999743271E-08 |
| Normal-VS-Type2 PRCC |
6.121600E-01 |
| Normal-VS-KIRP CIMP |
3.876000E-01 |
| Normal-VS-Unclassified PRCC |
1.70585000000001E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.506400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.572200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.699400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.187600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.806800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.396300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.37480000000656E-05 |
| Normal-vs-N1 |
3.024200E-01 |
| Normal-vs-N2 |
5.444800E-01 |
| N0-vs-N1 |
2.975700E-02 |
| N0-vs-N2 |
5.093400E-01 |
| N1-vs-N2 |
7.190000E-01 |
|
|
